Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Cannabidiol for the Treatment of Aromatase Inhibitor-Associated Arthralgias

Trial Status: complete

This phase II trial studies the effects of cannabidiol (CBD) in treating bothersome joint pain or stiffness (arthralgias), that is associated with taking an anti-hormone breast cancer treatment called an aromatase inhibitor. Cannabinoids, which are compounds derived from the cannabis plant, have been shown to reduce pain. CBD is one of these compounds. It does not have the psychoactive properties that people usually think of when they think about marijuana. CBD may help lessen the symptoms of arthralgia pain in patients receiving aromatase inhibitors for the treatment of breast cancer.